Boniva (ibandronate) is a part of the bisphosphonates drug family. After menopause, Boniva is prescribed to treat and prevent osteoporosis in women. Thinning of the bone can lead to bone fractures and breaks.
Boniva is a prescription drug that is indicated for the treatment and prevention of bone loss (osteoporosis) in women after menopause. Boniva belongs to a class of medicines known as bisphosphonates.
Boniva works by slowing down bone loss and weakening. Doing so helps the user maintain healthy bones and lowers the risk of broken bones.
The risk of developing osteoporosis increases after menopause, as you get older or if you use corticosteroids like prednisone for long periods. Osteoporosis causes your bones to become thinner, increasing the risk of fractures. Boniva is taken in the morning at least one hour before eating breakfast.